Stevanato Group S.p.A (STVN) Income from Continuing Operations (2020 - 2026)
Stevanato Group S.p.A (STVN) posted quarterly Income from Continuing Operations of 32812488.33 for Q1 2026, up 17.65% year-over-year from 27889664.03 in Q1 2025, and down 40.78% quarter-over-quarter from 55408471.3 in Q4 2025.
Stevanato Group S.p.A (STVN) Income from Continuing Operations (2020 - 2026) Analysis & Trends
Stevanato Group S.p.A (STVN) has reported Income from Continuing Operations for 7 consecutive years, with 32812488.33 the latest figure, recorded in Q1 2026.
- In Q1 2026, Income from Continuing Operations rose 17.65% year-over-year to 32812488.33; the TTM figure through Mar 2026 stood at 163966765.82 (up 21.72% YoY), while the FY2025 annual figure was 162733283.35, up 29.28% from the prior year.
- Income from Continuing Operations eased to 32812488.33 in Q1 2026 per STVN's latest filing, from 55408471.3 in the prior quarter.
- Across five years, Income from Continuing Operations topped out at 55408471.3 in Q4 2025 and bottomed at 20436637.56 in Q1 2024.
- Historically, Income from Continuing Operations has averaged 36845925.67 across 5 years, with a median of 33628258.41 in 2025.
- Annual changes were most pronounced in 2022 — Income from Continuing Operations soared 66.8% — and 2024, when it plunged 40.42%.
- Stevanato Group S.p.A's Income from Continuing Operations stood at 49277947.74 in 2022, then retreated by 1.31% to 48632483.89 in 2023, then rose by 6.13% to 51613157.83 in 2024, then advanced by 7.35% to 55408471.3 in 2025, then plunged by 40.78% to 32812488.33 in 2026.
- Business Quant data shows STVN's Income from Continuing Operations at 32812488.33 in Q1 2026, 55408471.3 in Q4 2025, and 42117547.78 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 823.20 Mn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 452.00 Mn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | - |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 383.43 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 139.00 Mn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 147.90 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 93.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | -77.90 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 135.00 Mn |
| 10 | Stevanato Group S.p.A | 6.18 Bn | 6.07 Bn | 100.91 Mn | 26.68 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 26.68 Mn |
| Mar 31, 2026 | 32.81 Mn |
| Dec 31, 2025 | 55.41 Mn |
| Sep 30, 2025 | 42.12 Mn |
| Jun 30, 2025 | 33.63 Mn |
| Mar 31, 2025 | 27.89 Mn |
| Dec 31, 2024 | 51.61 Mn |
| Sep 30, 2024 | 32.95 Mn |
| Jun 30, 2024 | 22.26 Mn |
| Mar 31, 2024 | 20.44 Mn |
| Dec 31, 2023 | 48.63 Mn |
| Sep 30, 2023 | 41.25 Mn |
| Jun 30, 2023 | 37.36 Mn |
| Mar 31, 2023 | 30.32 Mn |
| Dec 31, 2022 | 49.28 Mn |
| Sep 30, 2022 | 36.59 Mn |
| Jun 30, 2022 | 32.68 Mn |
| Mar 31, 2022 | 31.16 Mn |
| Dec 31, 2021 | 51.02 Mn |
| Sep 30, 2021 | 21.93 Mn |